PreveCeutical Medical Inc (18H) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.070x

Based on the latest financial reports, PreveCeutical Medical Inc (18H) has a cash flow conversion efficiency ratio of 0.070x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-520.46K ≈ $-608.47K USD) by net assets (€-7.39 Million ≈ $-8.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of PreveCeutical Medical Inc for the company's overall valuation and market capitalisation.

PreveCeutical Medical Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how PreveCeutical Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PreveCeutical Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PreveCeutical Medical Inc ranked by their cash flow conversion efficiency. Explore PreveCeutical Medical Inc cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
REDSUN PROPERTIES GROUP F:0RJ	N/A
FW Thorpe PLC LSE:TFW	0.081x
EMPYREAN ENERGY LS-002 F:E1E	N/A
Archon Minerals Ltd V:ACS	-0.007x
Weaccess Group SA PA:MLWEA	0.230x
Zephyr Minerals Ltd V:ZFR	0.006x
Pembroke VCT PLC LSE:PEMB	-0.009x
Central Asia Metals Plc LSE:CAML	0.174x

Annual Cash Flow Conversion Efficiency for PreveCeutical Medical Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of PreveCeutical Medical Inc from 2016 to 2024. View PreveCeutical Medical Inc stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-6.64 Million ≈ $-7.76 Million	€-426.69K ≈ $-498.85K	0.064x	+25.09%
2023-12-31	€-5.78 Million ≈ $-6.76 Million	€-296.97K ≈ $-347.19K	0.051x	-47.18%
2022-12-31	€-4.64 Million ≈ $-5.42 Million	€-450.99K ≈ $-527.25K	0.097x	-6.35%
2021-12-31	€-4.10 Million ≈ $-4.80 Million	€-426.39K ≈ $-498.49K	0.104x	+679.67%
2020-12-31	€-3.60 Million ≈ $-4.21 Million	€64.59K ≈ $75.52K	-0.018x	-108.09%
2019-12-31	€-4.49 Million ≈ $-5.25 Million	€-993.94K ≈ $-1.16 Million	0.222x	-93.32%
2018-12-31	€-2.29 Million ≈ $-2.67 Million	€-7.57 Million ≈ $-8.85 Million	3.314x	-73.46%
2017-12-31	€-344.34K ≈ $-402.57K	€-4.30 Million ≈ $-5.03 Million	12.485x	+181.02%
2016-12-31	€-296.06K ≈ $-346.13K	€-1.32 Million ≈ $-1.54 Million	4.443x	--

About PreveCeutical Medical Inc

F:18H Germany Biotechnology

Market Cap

$3.34 Million

€2.85 Million EUR

Market Cap Rank

#29390 Global

#2539 in Germany

Share Price

€0.01

Change (1 day)

-54.55%

52-Week Range

€0.01 - €0.03

All Time High

€0.13